시장보고서

상품코드

1781990

자기 혈당 측정 기기 시장 : 제품 유형별, 기술별, 검사 부위별, 환자 유형별, 최종사용자별, 국가별, 지역별 : 세계 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Self-monitoring Blood Glucose Devices Market, By Product Type, By Technology, By Testing Site, By Patient Type, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

발행일: 2025년 07월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 284 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

자기 혈당 측정 기기 시장 규모는 2024년에 197억 5,201만 달러에 달하며, 2025-2032년에 CAGR 11.53%로 확대

혈당 자가 측정 기기 시장 - 시장 역학

당뇨병 유병률 증가와 기술 혁신으로 자가혈당측정기 수요 증가 전망

당뇨병 유병률 증가와 급속한 기술 혁신이 맞물려 자가 혈당 측정 기기가 전 세계에서 보급되고 있습니다. 국제당뇨병연맹(International Diabetes Federation)은 전 세계 성인 10명 중 1명이 당뇨병을 앓고 있다고 보고하고 있으며, 효과적인 자가 관리 툴의 시급한 필요성을 강조하고 있습니다. 비침습적 센서와 모바일 앱 통합 등의 발전으로 혈당 모니터링이 더욱 편리하고 정확해지고 있습니다. 미국 질병예방통제센터(CDC)는 정기적인 혈당 모니터링이 합병증을 크게 줄이고 당뇨병 환자의 삶의 질을 향상시킬 수 있다고 강조하고 있습니다. 또한 인도와 브라질과 같은 국가에서는 정부 의료 프로그램이 보조금과 인식 개선 캠페인을 통해 이러한 기기에 대한 접근성을 높여 수백만 명의 환자가 보다 효과적으로 질병을 관리하고 의료 시스템의 부담을 줄이는 데 도움을 주고 있습니다.

자가 혈당 측정 기기 시장 - 주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면 세계 시장은 예측 기간(2025-2032년) 동안 연평균 약 11.53%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다.

제품 유형별로는 자가혈당측정기(SMBG)가 2024년 가장 큰 시장 점유율을 차지했습니다.

기술별로는 2024년 전기화학 기술이 주요 기술이었습니다.

검사 부위별로는 손가락 끝이 2024년 주요 검사 부위입니다.

환자 유형별로는 2024년 2형 당뇨병이 1위

최종사용자별로 보면 2024년 주요 최종사용자는 재택치료였습니다.

지역별로는 북미가 2024년 매출 1위를 기록했습니다.

혈당 자가 측정 기기 시장 - 세분화 분석

자가혈당측정기 세계 시장은 제품 유형, 기술, 검사 부위, 환자 유형, 최종사용자, 지역에 따라 세분화됩니다.

시장은 제품 유형에 따라 네 가지 범주로 나뉩니다. 자가혈당측정기(SMBG), 검사지, 란셋, 지속혈당측정기입니다. 혈당 자가 측정(SMBG) 측정기는 디지털 측정값으로 편리한 추적을 제공하며, 검사 스트립은 정확하고 빠른 결과를 보장합니다. 랜싯은 채혈에 필수적이며, 불편함을 최소화할 수 있습니다. 지속적 혈당 모니터는 실시간 혈당 추적을 가능하게 하여 더 나은 당뇨병 관리를 위한 견인차 역할을 하고 있습니다.

시장은 기술에 따라 두 가지 범주로 나뉩니다. 전기화학식과 광도계식입니다. 전기화학 기술은 정확성, 휴대성, 비용 효율성에서 우위를 점하고 있으며, SMBG 장비에 많이 사용되고 있습니다. 광도 측정 기술은 널리 보급되지는 않았지만, 시각적 선명도와 해석의 용이성으로 인해 초기 모델과 특정 임상 응용에 자주 활용되고 있습니다.

자가 혈당 측정 기기 시장 - 지역적 인사이트

혈당 자가 측정 기기 시장은 헬스케어 인프라, 당뇨병 유병률, 기술 도입의 영향을 받는 지역 역학을 보여줍니다. 북미는 첨단화된 의료 시스템과 높은 당뇨병 유병률로 인해 혈당 모니터링 기기에 대한 수요를 주도하고 있습니다. 그 다음으로는 유럽이 탄탄한 헬스케어 정책과 많은 당뇨병 인구가 특징입니다. 아시아태평양은 당뇨병 유병률 증가, 의료 인프라 개선, 당뇨병 관리에 대한 인식 증가로 인해 빠르게 성장하고 있습니다. 중국, 인도, 일본과 같은 국가들이 이러한 확장의 최전선에 있습니다. 라틴아메리카와 중동 및 아프리카는 의료 서비스 접근성 향상과 건강 인식의 향상에 힘입어 이러한 기술을 점차 도입하고 있습니다. 전반적으로 시장 성장은 지역별 의료 우선순위, 경제 상황, 당뇨병과 관련된 건강 문제 해결의 시급성에 따라 결정될 것입니다.

자가혈당측정기 시장 - 경쟁 구도

자가혈당측정(SMBG) 기기 시장은 기존 진입기업과 신생 혁신기업의 치열한 경쟁이 특징입니다. Abbott Laboratories, Dexcom, Roche Diagnostics, LifeScan, Ascensia Diabetes Care 등 주요 기업은 첨단 기술과 광범위한 판매망으로 시장을 독점하고 있습니다. Abbott의 FreeStyle Libre 시리즈는 센서 기술과 합리적인 가격으로 포도당 모니터링에 혁명을 일으켰으며, Dexcom의 G6 및 G7 시스템은 정확성과 사용자 친화적인 디자인으로 유명합니다. Roche의 Accu-Chek 시리즈는 신뢰성과 디지털 헬스 플랫폼과의 통합을 중시하여 많은 사람들의 신뢰를 받고 있습니다. LifeScan의 OneTouch 제품은 단순함과 정확성을 추구한 설계로 다양한 사용자층을 대상으로 합니다. Ascensia의 Contour 시리즈는 신뢰성과 사용자 친화적인 디자인으로 유명합니다. 또한 운동선수와 건강 지향적 소비자 모두를 대상으로 하는 지속형 혈당 측정기 Ultrahuman M1을 출시한 Ultrahuman과 같은 신규 진출기업도 시장에 진입하고 있습니다. 전략적 제휴, 기술 발전, 사용자 중심 설계에 대한 집중은 SMBG 장비 시장의 경쟁과 혁신을 촉진하는 주요 요인입니다.

서론
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 네덜란드
- 스웨덴
- 러시아
- 폴란드
- 기타
아시아태평양
- 개요
- 아시아태평양의 주요 제조업체
- 중국
- 인도
- 일본
- 한국
- 호주
- 인도네시아
- 태국
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 튀르키예
- 알제리
- 이집트
- 기타

제13장 주요 벤더 분석 - 자기 혈당 측정 기기 산업

경쟁 대시보드
- 경쟁 벤치마킹
- 경쟁 포지셔닝
기업 개요
- Abbott Laboratories
- Acon Laboratories, Inc.
- ARKRAY, Inc.
- Ascensia Diabetes Care
- B. Braun Melsungen AG
- Bayer AG
- Dexcom, Inc.
- Eli Lilly and Company
- GlucoMe
- i-SENS, Inc.
- LifeScan, Inc.
- Medtronic plc
- Nipro Corporation
- Nova Biomedical
- PHC Holdings Corporation
- Roche Diagnostics
- Sanofi
- Terumo Corporation
- Trividia Health, Inc.
- Ypsomed Holding AG

제14장 애널리스트의 전방위 전망

KSA 25.08.08

REPORT HIGHLIGHT

Self-monitoring Blood Glucose Devices Market size was valued at US$ 19,752.01 Million in 2024, expanding at a CAGR of 11.53% from 2025 to 2032.

The Self-monitoring Blood Glucose Devices Market involves portable devices that enable individuals to measure their blood glucose levels independently, playing a crucial role in diabetes management worldwide. Rising diabetes prevalence and increasing awareness about self-care practices are expanding the demand for these devices. According to the World Health Organization, over 422 million people globally are affected by diabetes, emphasizing the importance of regular glucose monitoring. However, challenges such as high costs of advanced devices and limited accessibility in low-income regions can hinder widespread adoption. Opportunities lie in technological advancements like continuous glucose monitoring integration, non-invasive sensors, and smartphone connectivity, which improve user experience and data accuracy. Additionally, growing government initiatives promoting diabetes screening and management are enhancing market penetration, especially in developing countries where early diagnosis and consistent monitoring can significantly improve patient outcomes.

Self-monitoring Blood Glucose Devices Market- Market Dynamics

Rising diabetes prevalence and tech innovations to boost self-monitoring glucose device demand

Rising diabetes prevalence combined with rapid technological innovations is driving greater adoption of self-monitoring blood glucose devices globally. The International Diabetes Federation reports that approximately 1 in 10 adults worldwide lives with diabetes, underscoring the urgent need for effective self-care tools. Advances such as non-invasive sensors and mobile app integration are making glucose monitoring more convenient and accurate. The U.S. Centers for Disease Control and Prevention (CDC) emphasizes that regular blood glucose monitoring can significantly reduce complications and improve quality of life for diabetic patients. Furthermore, government health programs in countries like India and Brazil are increasing access to these devices through subsidies and awareness campaigns, helping millions manage their condition more effectively and reducing the burden on healthcare systems.

Self-monitoring Blood Glucose Devices Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.53% over the forecast period (2025-2032)

Based on product type segmentation, Self-Monitoring Blood Glucose (SMBG) Meters were predicted to show maximum market share in the year 2024

Based on Technology segmentation, Electrochemical technology was the leading Technology in 2024

Based on Testing Site segmentation, Fingertip was the leading Testing Site in 2024

Based on Patient Type segmentation, Type 2 Diabetes was the leading Patient Type in 2024

Based on end user segmentation, Home Care was the leading end user in 2024

On the basis of region, North America was the leading revenue generator in 2024

Self-monitoring Blood Glucose Devices Market- Segmentation Analysis:

The Global Self-monitoring Blood Glucose Devices Market is segmented on the basis of Product Type, Technology, Testing Site, Patient Type, End User, and Region.

The market is divided into four categories based on product type: Self-Monitoring Blood Glucose (SMBG) Meters, Test Strips, Lancets, and Continuous Glucose Monitors. Self-Monitoring Blood Glucose (SMBG) Meters offer convenient tracking with digital readings, while Test Strips ensure accuracy and quick results. Lancets are vital for blood sampling, offering minimal discomfort. Continuous Glucose Monitors enable real-time glucose tracking, gaining traction for better diabetes management.

The market is divided into two categories based on Technology: Electrochemical and Photometric. Electrochemical technology dominates due to its precision, portability, and cost-effectiveness, commonly used in SMBG devices. Photometric technology, though less prevalent, is valued for its visual clarity and ease of interpretation, often utilized in earlier models and specific clinical applications.

Self-monitoring Blood Glucose Devices Market- Geographical Insights

The Self-Monitoring Blood Glucose Devices Market exhibits regional dynamics influenced by healthcare infrastructure, diabetes prevalence, and technological adoption. North America leads with advanced healthcare systems and high diabetes rates, driving demand for glucose monitoring devices. Europe follows, characterized by robust healthcare policies and a significant diabetic population. The Asia-Pacific region is experiencing rapid growth due to increasing diabetes prevalence, improving healthcare infrastructure, and rising awareness about diabetes management. Countries like China, India, and Japan are at the forefront of this expansion. Latin America and the Middle East & and Africa are gradually adopting these technologies, supported by improving healthcare access and rising health awareness. Overall, the market's growth is shaped by regional healthcare priorities, economic conditions, and the urgency of addressing diabetes-related health challenges.

Self-monitoring Blood Glucose Devices Market- Competitive Landscape:

The Self-Monitoring Blood Glucose (SMBG) Devices Market is characterized by intense competition among established players and emerging innovators. Leading companies such as Abbott Laboratories, Dexcom, Roche Diagnostics, LifeScan, and Ascensia Diabetes Care dominate the market with their advanced technologies and extensive distribution networks. Abbott's FreeStyle Libre series has revolutionized glucose monitoring with its sensor technology and affordability, while Dexcom's G6 and G7 systems are renowned for their accuracy and user-friendly design. Roche's Accu-Chek line continues to be a trusted choice for many, emphasizing reliability and integration with digital health platforms. LifeScan's OneTouch products are designed for simplicity and accuracy, catering to a broad user base. Ascensia's Contour series is known for its reliability and user-friendly design. The market is also witnessing the entry of new players like Ultrahuman, which launched its continuous glucose monitor, Ultrahuman M1, targeting both athletes and health-conscious consumers. Strategic collaborations, technological advancements, and a focus on user-centric designs are key factors driving competition and innovation in the SMBG devices market.

Recent Developments:

In July 2024, Roche received CE Mark for its Accu-Chek SmartGuide(R) continuous glucose monitoring (CGM) device. Designed for adults with type 1 and type 2 diabetes, it offers real-time glucose readings and AI-powered predictive alerts for improved self-management.

In May 2024, Intuity Medical and embecta have announced a commercial collaboration to expand access to Intuity's POGO Automatic(R) Blood Glucose Monitoring System, aiming to enhance self-monitoring options and diabetes care for patients across the United States.

In April 2023, Astellas and Roche Diabetes Care Japan partnered to develop and commercialize an integrated diabetes self-management solution featuring Roche's blood glucose monitoring devices and the BlueStar digital health platform, aiming to improve diabetes care in Japan.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbott Laboratories
Acon Laboratories, Inc.
ARKRAY, Inc.
Ascensia Diabetes Care
B. Braun Melsungen AG
Bayer AG
Dexcom, Inc.
Eli Lilly and Company
GlucoMe
i-SENS, Inc.
LifeScan, Inc.
Medtronic plc
Nipro Corporation
Nova Biomedical
PHC Holdings Corporation
Roche Diagnostics
Sanofi
Terumo Corporation
Trividia Health, Inc.
Ypsomed Holding AG

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

Self-Monitoring Blood Glucose (SMBG) Meters
Test Strips
Lancets
Continuous Glucose Monitors

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

Electrochemical
Photometric

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY TESTING SITE- MARKET ANALYSIS, 2019 - 2032

Fingertip
Alternate Site Testing

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PATIENT TYPE- MARKET ANALYSIS, 2019 - 2032

Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

Hospitals
Ambulatory Surgery Centers
Diagnostics Center
Home Care
Other

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Self-monitoring Blood Glucose Devices Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Self-monitoring Blood Glucose Devices Market Snippet by Product Type
- 2.1.2. Self-monitoring Blood Glucose Devices Market Snippet by Technology
- 2.1.3. Self-monitoring Blood Glucose Devices Market Snippet by Testing Site
- 2.1.4. Self-monitoring Blood Glucose Devices Market Snippet by Patient Type
- 2.1.5. Self-monitoring Blood Glucose Devices Market Snippet by End User
- 2.1.6. Self-monitoring Blood Glucose Devices Market Snippet by Country
- 2.1.7. Self-monitoring Blood Glucose Devices Market Snippet by Region
2.2. Competitive Insights

3. Self-monitoring Blood Glucose Devices Key Market Trends

3.1. Self-monitoring Blood Glucose Devices Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Self-monitoring Blood Glucose Devices Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Self-monitoring Blood Glucose Devices Market Opportunities
3.4. Self-monitoring Blood Glucose Devices Market Future Trends

4. Self-monitoring Blood Glucose Devices Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Self-monitoring Blood Glucose Devices Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Self-monitoring Blood Glucose Devices Market Landscape

6.1. Self-monitoring Blood Glucose Devices Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Self-monitoring Blood Glucose Devices Market - By Product Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
- 7.1.2. Self-Monitoring Blood Glucose (SMBG) Meters
- 7.1.3. Test Strips
- 7.1.4. Lancets
- 7.1.5. Continuous Glucose Monitors

8. Self-monitoring Blood Glucose Devices Market - By Technology

8.1. Overview
- 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
- 8.1.2. Electrochemical
- 8.1.3. Photometric

9. Self-monitoring Blood Glucose Devices Market - By Testing Site

9.1. Overview
- 9.1.1. Segment Share Analysis, By Testing Site, 2024 & 2032 (%)
- 9.1.2. Fingertip
- 9.1.3. Alternate Site Testing

10. Self-monitoring Blood Glucose Devices Market - By Patient Type

10.1. Overview
- 10.1.1. Segment Share Analysis, By Patient Type, 2024 & 2032 (%)
- 10.1.2. Type 1 Diabetes
- 10.1.3. Type 2 Diabetes
- 10.1.4. Gestational Diabetes

11. Self-monitoring Blood Glucose Devices Market - By End User

11.1. Overview
- 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
- 11.1.2. Hospitals
- 11.1.3. Ambulatory Surgery Centers
- 11.1.4. Diagnostics Center
- 11.1.5. Home Care
- 11.1.6. Other

12. Self-monitoring Blood Glucose Devices Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Self-monitoring Blood Glucose Devices Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Self-monitoring Blood Glucose Devices Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.10. UK
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.10.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.3.10.5. UK Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.3.10.6. UK Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.11. France
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.11.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.3.11.5. France Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.3.11.6. France Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.12. Italy
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.12.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.3.12.5. Italy Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.3.12.6. Italy Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.13. Spain
  - 12.3.13.1. Overview
  - 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.13.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.3.13.5. Spain Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.3.13.6. Spain Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.14. The Netherlands
  - 12.3.14.1. Overview
  - 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.3.14.5. The Netherlands Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.3.14.6. The Netherlands Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Overview
  - 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.16. Russia
  - 12.3.16.1. Overview
  - 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.16.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.3.16.5. Russia Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.3.16.6. Russia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.17. Poland
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.17.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.3.17.5. Poland Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.3.17.6. Poland Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.18. Rest of Europe
  - 12.3.18.1. Overview
  - 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.3.18.5. Rest of the Europe Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.3.18.6. Rest of the Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Self-monitoring Blood Glucose Devices Key Manufacturers in Asia Pacific
- 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.6. APAC Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
- 12.4.7. APAC Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
- 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.9. China
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.9.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.4.9.5. China Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.4.9.6. China Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.10. India
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.10.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.4.10.5. India Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.4.10.6. India Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.14. Indonesia
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.4.14.5. Indonesia Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.4.14.6. Indonesia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.15. Thailand
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.15.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.4.15.5. Thailand Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.4.15.6. Thailand Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.17. Rest of APAC
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.17.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.4.17.5. Rest of APAC Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.4.17.6. Rest of APAC Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
- 12.5.1. Overview
- 12.5.2. Self-monitoring Blood Glucose Devices Key Manufacturers in Latin America
- 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.5.6. LATAM Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
- 12.5.7. LATAM Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
- 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Self-monitoring Blood Glucose Devices Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.15. Rest of MEA
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.15.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 12.6.15.5. Rest of MEA Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
  - 12.6.15.6. Rest of MEA Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Self-monitoring Blood Glucose Devices Industry

13.1. Competitive Dashboard
- 13.1.1. Competitive Benchmarking
- 13.1.2. Competitive Positioning
13.2. Company Profiles
- 13.2.1. Abbott Laboratories
- 13.2.2. Acon Laboratories, Inc.
- 13.2.3. ARKRAY, Inc.
- 13.2.4. Ascensia Diabetes Care
- 13.2.5. B. Braun Melsungen AG
- 13.2.6. Bayer AG
- 13.2.7. Dexcom, Inc.
- 13.2.8. Eli Lilly and Company
- 13.2.9. GlucoMe
- 13.2.10. i-SENS, Inc.
- 13.2.11. LifeScan, Inc.
- 13.2.12. Medtronic plc
- 13.2.13. Nipro Corporation
- 13.2.14. Nova Biomedical
- 13.2.15. PHC Holdings Corporation
- 13.2.16. Roche Diagnostics
- 13.2.17. Sanofi
- 13.2.18. Terumo Corporation
- 13.2.19. Trividia Health, Inc.
- 13.2.20. Ypsomed Holding AG

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us